MMedication Read More FDA to offer bonus payments to staffers who complete speedy drug reviewsFebruary 28, 2026 WASHINGTON (AP) — The head of the Food and Drug Administration plans to start offering bonus payments to…
MMedication Read More FDA plans bonuses to staffers who complete speedy drug reviewsFebruary 27, 2026 WASHINGTON (AP) — The head of the Food and Drug Administration plans to start offering bonus payments to…
MMedication Read More FDA will drop two-study requirement for new drug approvals, aiming to speed accessFebruary 19, 2026 WASHINGTON (AP) — The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous…
MMedication Read More FDA will drop two-study requirement for new drug approvals, aiming to speed accessFebruary 19, 2026 WASHINGTON (AP) — The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous…
MMedication Read More More drugs should be over-the-counterFebruary 18, 2026 Food and Drug Administration Commissioner Marty Makary told CNBC that he believes “everything should be over the counter”…
MMedication Read More FDA’s drug voucher program: House lawmaker raises new concernsFebruary 3, 2026 WASHINGTON (AP) — A Democratic lawmaker is raising new concerns about a Food and Drug Administration program designed…
MMedication Read More FDA commissioner’s drug review plan sparks alarmJanuary 16, 2026 WASHINGTON (AP) — The Food and Drug Administration commissioner’s effort to drastically shorten the review of drugs favored…
MMedication Read More Takeaways on turmoil surrounding FDA fast-track drug programJanuary 16, 2026 WASHINGTON (AP) — A plan to slash drug review times at the Food and Drug Administration is sparking…
FFitness Read More US FDA to limit regulation of health and fitness wearables, commissioner saysJanuary 7, 2026 By Puyaan Singh Jan 6 (Reuters) – The U.S. Food and Drug Administration said on Tuesday that it…
HHealth care Read More Top FDA drug regulator plans to depart weeks into jobDecember 3, 2025 The nation’s top drug regulator, Richard Pazdur, has decided to retire three weeks after taking the job. Pazdur…
HHealth care Read More US to remove warnings from menopause hormone therapyNovember 11, 2025 The United States will remove strong safety warnings on many hormone therapies used to alleviate menopausal symptoms, saying…
HHealth Read More FDA removing warning from hormone-based menopause drugsNovember 10, 2025 WASHINGTON (AP) — Hormone-based drugs used to treat hot flashes and other menopause symptoms will no longer carry…